Abano Healthcare Group Limited reported unaudited consolidated earnings results for the six months ended November 30, 2017. For the six months, the company reported revenue of NZD 133,213,000 against NZD 116,809,000 a year ago. Operating profit was NZD 12,081,000 against NZD 11,262,000 a year ago. Profit before income tax was NZD 9,305,000 against NZD 8,606,000 a year ago. Profit for the period attributable to equity holders of the company share of profit was NZD 6,001,000 or 25.40 cents per share against NZD 5,874,000 or 27.48 cents per share a year ago. Net cash generated from operating activities of was NZD 12,057,000 against NZD 8,416,000 a year ago. Purchase of property, plant, equipment and intangible assets was NZD 8,871,000 against NZD 5,425,000 a year ago.

The company provided trading guidance for the second half of fiscal 2018. Trading in the second half is expected to continue the momentum seen in the first half.